Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | November 28, 2024 |
| PDB ID ▲ | UniProt ID | Title | Descriptor |
|---|---|---|---|
| 8DTC | L8GT25 | Crystal Structure of Glucokinase with bound glucose from Acanthamoeba castellanii | |
| 8DTK | P0DTC2 | Structure of RBD directed antibody DH1047 in complex with SARS-CoV-2 spike: Local refinement of RBD-Fab interace | |
| 8DTK | 8DTK | Structure of RBD directed antibody DH1047 in complex with SARS-CoV-2 spike: Local refinement of RBD-Fab interace | |
| 8DTO | 8DTO | Vaccine elicited Antibody MU89 bound to CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 Env trimer | |
| 8DU5 | O35657 | Murine sialidase-1 (NEU1) | |
| 8DUA | V9PL68 | SIV E660.CR54 SOS-2P Env Trimer with ITS92.02 | |
| 8DUA | C4NR77 | SIV E660.CR54 SOS-2P Env Trimer with ITS92.02 | |
| 8DUA | 8DUA | SIV E660.CR54 SOS-2P Env Trimer with ITS92.02 | |
| 8DUL | P13897 | Cryo-EM Structure of Antibody SKT05 in complex with Western Equine Encephalitis Virus spike (local refinement from VLP particles) | |
| 8DUL | 8DUL | Cryo-EM Structure of Antibody SKT05 in complex with Western Equine Encephalitis Virus spike (local refinement from VLP particles) | |
| 8DUN | P13897 | Cryo-EM Structure of Antibody SKW11 in complex with Western Equine Encephalitis Virus spike (local refinement from VLP particles) | |
| 8DUN | 8DUN | Cryo-EM Structure of Antibody SKW11 in complex with Western Equine Encephalitis Virus spike (local refinement from VLP particles) | |
| 8DV1 | P0DTC2 | SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to linker variant of affinity matured ACE2 mimetic CVD432 | |
| 8DV1 | P0DOX5 | SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to linker variant of affinity matured ACE2 mimetic CVD432 | |
| 8DV1 | Q9BYF1 | SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to linker variant of affinity matured ACE2 mimetic CVD432 | |
| 8DV2 | P0DTC2 | SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to computationally engineered ACE2 mimetic CVD293 | |
| 8DV2 | P0DOX5 | SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to computationally engineered ACE2 mimetic CVD293 | |
| 8DV2 | Q9BYF1 | SARS-CoV-2 Wuhan-hu-1-Spike-RBD bound to computationally engineered ACE2 mimetic CVD293 | |
| 8DV3 | P29016 | Crystal structure of human CD1b presenting Phosphatidylinositol C34:1 | |
| 8DV3 | P61769 | Crystal structure of human CD1b presenting Phosphatidylinositol C34:1 | |
| 8DV4 | P29016 | Crystal structure of the BC8B TCR-CD1b-PI complex | |
| 8DV4 | P61769 | Crystal structure of the BC8B TCR-CD1b-PI complex | |
| 8DV4 | 8DV4 | Crystal structure of the BC8B TCR-CD1b-PI complex | |
| 8DVD | A0A0C5JYT4 | Cryo-EM structure of SIVmac239 SOS-2P Env trimer in complex with human bNAb PGT145 | |
| 8DVD | A0A4Y5TGK0 | Cryo-EM structure of SIVmac239 SOS-2P Env trimer in complex with human bNAb PGT145 | |
| 8DVD | 8DVD | Cryo-EM structure of SIVmac239 SOS-2P Env trimer in complex with human bNAb PGT145 | |
| 8DVL | O75581 | Crystal structure of LRP6 E3E4 in complex with disulfide constrained peptide E3.18 | |
| 8DVL | 8DVL | Crystal structure of LRP6 E3E4 in complex with disulfide constrained peptide E3.18 | |
| 8DVM | O75581 | Crystal structure of LRP6 E3E4 in complex with disulfide constrained peptide E3.6 | |
| 8DVM | 8DVM | Crystal structure of LRP6 E3E4 in complex with disulfide constrained peptide E3.6 | |
| 8DVN | O75581 | Crystal structure of LRP6 E3E4 in complex with disulfide constrained peptide E3.10 | |
| 8DVN | 8DVN | Crystal structure of LRP6 E3E4 in complex with disulfide constrained peptide E3.10 | |
| 8DW2 | 8DW2 | Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR22, and two antibody Fabs, S309 and CR3022 | |
| 8DW2 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR22, and two antibody Fabs, S309 and CR3022 | |
| 8DW3 | 8DW3 | Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR16m, and two antibody Fabs, S309 and CR3022 | |
| 8DW3 | P0DTC2 | Cryo-EM structure of SARS-CoV-2 RBD in complex with anti-SARS-CoV-2 DARPin,SR16m, and two antibody Fabs, S309 and CR3022 | |
| 8DWA | P0DTC2 | Crystal structure of neutralizing antibody P1D9 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD) | |
| 8DWA | 8DWA | Crystal structure of neutralizing antibody P1D9 Fab in complex with SARS-CoV-2 spike receptor binding domain (RBD) | |
| 8DWB | Q8AZ87 | Neuraminidase from influenza virus A/Moscow/10/1999(H3N2) in complex with sialic acid | |
| 8DWD | P83847 | Adenine glycosylase MutY variant E43S in complex with DNA containing d(8-oxo-G) paired with an AP site generated by the enzyme acting on purine | |
| 8DWW | Q5XXP3 | Chikungunya VLP in complex with neutralizing Fab 506.A08 (asymmetric unit) | |
| 8DWW | 8DWW | Chikungunya VLP in complex with neutralizing Fab 506.A08 (asymmetric unit) | |
| 8DWX | Q5XXP3 | Chikungunya VLP in complex with neutralizing Fab 506.C01 (asymmetric unit) | |
| 8DWX | 8DWX | Chikungunya VLP in complex with neutralizing Fab 506.C01 (asymmetric unit) | |
| 8DWY | Q5XXP3 | Chikungunya VLP in complex with neutralizing Fab CHK-265 (asymmetric unit) | |
| 8DWY | 8DWY | Chikungunya VLP in complex with neutralizing Fab CHK-265 (asymmetric unit) | |
| 8DXS | P0DTC2 | Cryo-EM structure of RBD-directed neutralizing antibody P2B4 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
| 8DXS | 8DXS | Cryo-EM structure of RBD-directed neutralizing antibody P2B4 in complex with prefusion SARS-CoV-2 spike glycoprotein | |
| 8DXT | 8DXT | Fab arm of antibody GAR12 bound to the receptor binding domain of SARS-CoV-2. | |
| 8DXT | P0DTC2 | Fab arm of antibody GAR12 bound to the receptor binding domain of SARS-CoV-2. |
